<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Ea C</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Faciocraniosynostoses (FCS) are malformations affecting the development of the bones of the skull and face, due to the premature closure of one or more craniofacial sutures, mostly secondary to activating &lt;i>Fibroblast Growth Factor Receptor&lt;/i> (&lt;i>FGFR&lt;/i>) 1-3 mutations. Gain-of-function &lt;i>FGFR3&lt;/i> mutations are also responsible for various conditions referred to as osteochondrodysplasia (OCD), characterized by structural and functional abnormalities of growth plate cartilages. We hypothesized that patients with &lt;i>FGFR&lt;/i>-related faciocraniosynostoses may present extra-cranial growth anomalies.&lt;h4>Study design&lt;/h4>We retrospectively collected height and weight data from a cohort of 70 patients. Included patients were admitted for &lt;i>FGFR&lt;/i>-related FCS between 200</pubmed_abstract><journal>Bone reports</journal><pagination>101524</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8965158</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Growth charts in &lt;i>FGFR2&lt;/i>- and &lt;i>FGFR3&lt;/i>-related faciocraniosynostoses.</pubmed_title><pmcid>PMC8965158</pmcid><pubmed_authors>Collet C</pubmed_authors><pubmed_authors>Hennocq Q</pubmed_authors><pubmed_authors>Picard A</pubmed_authors><pubmed_authors>Polak M</pubmed_authors><pubmed_authors>Khonsari RH</pubmed_authors><pubmed_authors>Legeai-Mallet L</pubmed_authors><pubmed_authors>Paternoster G</pubmed_authors><pubmed_authors>Arnaud E</pubmed_authors><pubmed_authors>Ea C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Growth charts in &lt;i>FGFR2&lt;/i>- and &lt;i>FGFR3&lt;/i>-related faciocraniosynostoses.</name><description>&lt;h4>Objective&lt;/h4>Faciocraniosynostoses (FCS) are malformations affecting the development of the bones of the skull and face, due to the premature closure of one or more craniofacial sutures, mostly secondary to activating &lt;i>Fibroblast Growth Factor Receptor&lt;/i> (&lt;i>FGFR&lt;/i>) 1-3 mutations. Gain-of-function &lt;i>FGFR3&lt;/i> mutations are also responsible for various conditions referred to as osteochondrodysplasia (OCD), characterized by structural and functional abnormalities of growth plate cartilages. We hypothesized that patients with &lt;i>FGFR&lt;/i>-related faciocraniosynostoses may present extra-cranial growth anomalies.&lt;h4>Study design&lt;/h4>We retrospectively collected height and weight data from a cohort of 70 patients. Included patients were admitted for &lt;i>FGFR&lt;/i>-related FCS between 200</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-04T23:16:26.688Z</modification><creation>2025-04-04T23:16:26.688Z</creation></dates><accession>S-EPMC8965158</accession><cross_references><pubmed>35372644</pubmed><doi>10.1016/j.bonr.2022.101524</doi></cross_references></HashMap>